1. Home
  2. ALCO vs IPHA Comparison

ALCO vs IPHA Comparison

Compare ALCO & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

HOLD

Current Price

$41.26

Market Cap

297.9M

Sector

N/A

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

SELL

Current Price

$1.87

Market Cap

189.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ALCO
IPHA
Founded
1960
1999
Country
United States
France
Employees
N/A
163
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.9M
189.5M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
ALCO
IPHA
Price
$41.26
$1.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$44.00
$5.75
AVG Volume (30 Days)
19.4K
8.8K
Earning Date
05-11-2026
03-26-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$180.36
Revenue Next Year
N/A
N/A
P/E Ratio
$40.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.32
$1.18
52 Week High
$45.01
$2.63

Technical Indicators

Market Signals
Indicator
ALCO
IPHA
Relative Strength Index (RSI) 57.90 51.21
Support Level $39.94 $1.73
Resistance Level $42.06 $1.80
Average True Range (ATR) 0.82 0.09
MACD 0.15 -0.01
Stochastic Oscillator 84.51 27.60

Price Performance

Historical Comparison
ALCO
IPHA

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: